The details mention key figures like Tom Jefferson and Carl Heneghan, whose connections to Brownstone reportedly went undisclosed in the publication. This lack of disclosure appears to conflict with Cochrane's rigorous standards for transparency, causing concerns about the integrity of the process. Furthermore, it suggests that the editorial response did not adequately address these potential conflicts, fueling skepticism about the review's credibility.